Literature DB >> 11308257

Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue.

J Varani1, Y Hattori, M K Dame, T Schmidt, H S Murphy, K J Johnson, K J Wojno.   

Abstract

Prostate tissue was obtained from 22 radical prostatectomies (performed for clinical management of prostate carcinoma) immediately after surgery. A small piece of tissue was fixed immediately in formalin and used for routine histology while a second piece was frozen in OCT and used for immuno-histochemistry. Another small piece was used for isolation of epithelial and stromal cells. The remainder of the tissue was cut into 2 x 2 mm pieces and incubated in organ culture for 8 days. In organ culture, non-malignant, basal epithelial cells underwent a proliferative response. This was accompanied by de-differentiation of glandular structures and by migration of epithelial cells across the surface of the tissue. Erosion of the basement membrane could also be seen in places, but was not widespread. Invasion of epithelial cells into the adjacent stroma was not evident. Production of matrix metalloproteinases (MMPs) with gelatinolytic activity or collagenolytic activity was assessed in organ culture and compared to expression patterns in fresh tissue. MMP-1 (interstitial collagenase) and MMP-9 (92-kDa gelatinase B) were undetectable or low in fresh tissue specimens. Both enzymes were detected in organ culture and both increased over time. Even after 6 days, however, there was only a low level of gelatin-hydrolytic activity and no measurable collagen-hydrolytic activity. In past studies we used organ cultures of normal skin and malignant skin tumours (basal cell carcinomas) to help elucidate the role of collagenolytic and gelatinolytic MMPs in epithelial cell invasion (Varani et al, 2000). Compared to MMP levels observed in skin, levels of these enzymes in prostate are low. The low level of collagenolytic and gelatinolytic MMPs in fresh prostate tissue and in organ-cultured prostate tissue may help explain why there is little tissue destruction in many primary prostate tumours and why the majority of such tumours remain confined to the prostate for extended periods. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308257      PMCID: PMC2363871          DOI: 10.1054/bjoc.2000.1712

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

Review 1.  The matrix metalloproteinases and their inhibitors.

Authors:  G Murphy; A J Docherty
Journal:  Am J Respir Cell Mol Biol       Date:  1992-08       Impact factor: 6.914

2.  Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours.

Authors:  D Muller; R Breathnach; A Engelmann; R Millon; G Bronner; H Flesch; P Dumont; M Eber; J Abecassis
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

3.  Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.

Authors:  Y A DeClerck; N Perez; H Shimada; T C Boone; K E Langley; S M Taylor
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

4.  Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.

Authors:  M E Zeigler; Y Chi; T Schmidt; J Varani
Journal:  J Cell Physiol       Date:  1999-08       Impact factor: 6.384

5.  Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.

Authors:  Y A DeClerck; T D Yean; D Chan; H Shimada; K E Langley
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

6.  Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.

Authors:  S McDonnell; M Navre; R J Coffey; L M Matrisian
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

7.  Interstitial collagenase gene expression in oral squamous cell carcinoma.

Authors:  S T Gray; R J Wilkins; K Yun
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

8.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.

Authors:  C Pyke; E Ralfkiaer; P Huhtala; T Hurskainen; K Danø; K Tryggvason
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

Review 9.  Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.

Authors:  R Khokha; D T Denhardt
Journal:  Invasion Metastasis       Date:  1989

10.  Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.

Authors:  C M Alexander; Z Werb
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  7 in total

1.  Differentiation of prostate epithelial cell cultures by matrigel/ stromal cell glandular reconstruction.

Authors:  Shona H Lang; Joel Smith; Catherine Hyde; Catherine Macintosh; Michael Stower; Norman J Maitland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Sep-Oct       Impact factor: 2.416

2.  Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.

Authors:  Safwan Escaff; Jesús M Fernández; Luis O González; Aurelio Suárez; Salomé González-Reyes; José M González; Francisco J Vizoso
Journal:  World J Urol       Date:  2010-10-01       Impact factor: 4.226

3.  Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors:  Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

4.  Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies.

Authors:  C A Hart; L J Scott; S Bagley; A A G Bryden; N W Clarke; S H Lang
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

5.  Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Authors:  S Escaff; J M Fernández; L O González; A Suárez; S González-Reyes; J M González; F J Vizoso
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

6.  The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.

Authors:  C-H Chuang; W-J Wang; C-F Li; C-Y Ko; Y-H Chou; C-P Chuu; T-L Cheng; J-M Wang
Journal:  Cell Death Dis       Date:  2014-05-08       Impact factor: 8.469

7.  Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.

Authors:  Yixuan Gong; Uma D Chippada-Venkata; William K Oh
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.